MERTK and breast cancer: MerTK genetic ablation or inhibition by small molecules in leukocytes decreases tumor growth and enhances anti-tumor immune response by switching myeloid cell cytokine production from an immunosuppressive to an inflammatory state in an immunocompetent mouse model of breast cancer (18, 19).